The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
A&O Enterprises, doing business as iV Bars, and Aaron K. Roberts, In the Matter of
Following a public comment period, the FTC has approved a final order settling charges against a Texas-based marketer and seller of intravenously injected therapy products (IV Cocktails) who allegedly made a range of deceptive and unsupported health claims about their ability to treat serious diseases such as cancer, multiple sclerosis, and congestive heart failure.
Cephalon, Inc.
On 2/13/2008, the Commission filed a complaint in federal district court charging Cephalon, Inc. with preventing competition to its branded drug Provigil. The conduct under challenge includes paying four firms to refrain from selling generic versions of Provigil until 2012. Cephalon’s anticompetitive scheme, according to the Commission, denies patients access to lower-cost, generic versions of Provigil and forces consumers and other purchasers to pay hundreds of millions of dollars a year more for Provigil. According to the complaint, Cephalon entered into agreements with four generic drug manufacturers that each planned to sell a generic version of Provigil. Each of these companies had challenged the only remaining patent covering Provigil, one relating to the size of particles used in the product. The complaint charges that Cephalon was able to induce each of the generic companies to abandon its patent challenge and agree to refrain from selling a generic version of Provigil until 2012 by agreeing to pay the companies a total amount in excess of $200 million. In so doing, Cephalon achieved a result that assertion of its patent rights alone could not. In 2008, this case was transferred from the District Court of District of Columbia to the District Court for the Eastern District of Pennsylvania.
Statement of Chairman Simons, Commissioner Phillips, and Commissioner Wilson Concerning the Proposed Acquisition of NxStage Medical, Inc. by Fresenius Medical Care AG & Co. KGaA
Statement of Commissioner Chopra In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.
Statement of Commissioner Slaughter In the Matter of Fresenius Medical Care AG & Co. KGaA and NxStage Medical, Inc.
Tronox Limited, et al.
FTC Bureau of Competition Director Bruce Hoffman issued the following statement regarding the U.S. District Court ruling today that granted the FTC’s request for a preliminary injunction in the proposed merger of Tronox Limited and Cristal. The companies are top suppliers in the United States and Canada of chloride process titanium dioxide (TiO2), a white pigment used in paints, industrial coatings, plastic and paper:
20190817: Chevron Corporation; Petroleo Brasileiro S.A.
Fat Giraffe Marketing Group LLC
The defendants in an alleged work-from-home business opportunity scam are banned from selling any business coaching service or business opportunity under a settlement with the Federal Trade Commission.
WV Universal Management, LLC
The FTC is mailing 1,244 checks to consumers who bought deceptively marketed credit card interest rate reduction services after being contacted via illegal robocalls. Affected consumers will receive full refunds, with most receiving $1,100 or more, within the next week.
1902002 Informal Interpretation
16 CFR Part 436: Disclosure Requirements and Prohibitions Concerning Franchising Rule (Franchise Rule)
Inside Publications, LLC, In the Matter of
Following a public comment period, the FTC has approved two final orders settling allegations that Creaxion Corporation, Inside Publications, LLC, and their respective principals misrepresented that paid endorsements were independent consumer opinions and that commercial advertising was independent journalistic content.
Troth Solutions
The operators of a tech support scam that did business under Troth Solutions and other names settled Federal Trade Commission charges that they tricked consumers into believing their computers were infected with viruses and malware, and then charged them hundreds of dollars for unnecessary repairs.
Anthony Dill, Staci Dill, Direct Alternatives and Original Organics LLC
The FTC is mailing 104,612 checks totaling nearly $3.5 million to people who bought weight-loss supplements marketed by Maine-based sellers Direct Alternatives and Original Organics, LLC. Affected consumers will receive their refund checks, which average $33.12, within the next week. The FTC and the Maine AG’s Office obtained the money in the settlement of two related cases against these sellers and a marketing company that created and disseminated advertisements for Direct Alternative’s weight-loss products.
Creaxion Corp., In the Matter of
Following a public comment period, the FTC has approved two final orders settling allegations that Creaxion Corporation, Inside Publications, LLC, and their respective principals misrepresented that paid endorsements were independent consumer opinions and that commercial advertising was independent journalistic content.
20190770: NGL Energy Partners LP; DCP Midstream Partners, LP
Global Asset Financial Services Group, LLC
10 Companies and 10 individuals settled Federal Trade Commission allegations that their deceptive and unfair tactics violated the FTC Act and the Fair Debt Collection Practice Act. The action is part of the FTC's continuing crackdown on all players involved in phantom debt schemes, including those who sell fake debt portfolios and those who harass consumers to collect the phony debt.
The Federal Trade Commission is sending payments totaling more than $1 million to 1,966 consumers who were harmed by a debt collection scheme that conned consumers into paying debts they did not owe. The defendants used several names including GAFS Group, Global Mediation Group, and Mediation Services.
Marathon Petroleum, et al., In the Matter of
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Marathon Petroleum Corp.’s proposed acquisition of Express Mart would violate federal antitrust law.